Alkem Laboratories Limited (ALKEM) launches NeuCeno (cenobamate) for partial-onset seizures, marking a significant advancement in epilepsy treatment.
Alkem Laboratories Limited (ALKEM) launches Renocia Exo™, India’s first patented Ginsenoside exosome-based hair growth serum, addressing hair loss with regen.
Alkem Laboratories Limited (ALKEM) announces 11% revenue growth for Q1FY27, with strong performance in India and international markets.
Alkem Laboratories Limited (NSE: ALKEM) becomes the first in India to launch semaglutide in single-shot pre-filled syringes starting at INR 350.
Alkem Laboratories Limited (ALKEM) reports record high EBITDA and strong revenue growth for Q4 & FY26, with notable performance in domestic and international.